Aanika Dalal

To understand how to fix antibiotic access, we first need to understand where it's broken. Part 0: Methods We're working on a project to identify promising potential interventions for improving rates of access to antibiotics in low and middle income countries (LMICs). Before we start developing a long list of potential interventions, we wanted to take some time to understand what current barriers and bottlenecks prevent access to antibiotics. To do this, we decided to conduct an exploratory...

We have lifesaving antibiotics that are cheap, effective, and have existed for decades. They still fail to reach the patients who most need them. The antibiotic that would have saved a child's life might be: Not registered in their country. Registered, but caught in a supply chain disruption somewhere Manufactured and supplied, but missing from the national formulary or excluded by the procurement system. Procured, but unaffordable to a family paying out of pocket. Stocked, but degraded in...

Summary Recently, the Council agreed on its position on the Reform of the EU General Pharmaceutical Legislation , setting the stage for...